Learn / PTGX
NASDAQ: PTGX
Protagonist Therapeutics (PTGX) stock, explained like you're 5
Protagonist Therapeutics trades on the Nasdaq under the ticker PTGX. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 9.3 billion dollars.
- Ticker
- PTGX
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Mid cap, about 9.3 billion dollars
Is Protagonist Therapeutics a small, medium or large cap company?
No. Protagonist Therapeutics is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 9.3 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Protagonist Therapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves PTGX stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Protagonist Therapeutics, Inc. (PTGX) Stock Forecasts (Yahoo! Finance Canada)
- Protagonist Therapeutics (PTGX) Stock May Look Fully Priced On Earnings (Simply Wall Street)
- Protagonist Therapeutics (NASDAQ:PTGX): Strong Growth Meets Constructive Technical Setup (ChartMill)
- Here's How Much $100 Invested In Protagonist Therapeutics 10 Years Ago Would Be Worth Today (Benzinga)
- Protagonist Therapeutics (NASDAQ:PTGX) Raised to Strong Buy at Zacks Research (MarketBeat)
Follow PTGX in your daily brief
Each trading day at 5 PM ET we post what happened to Protagonist Therapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow PTGX
Questions about Protagonist Therapeutics stock
What does Protagonist Therapeutics do?
Protagonist Therapeutics trades on the Nasdaq under the ticker PTGX. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 9.3 billion dollars.
What is the ticker symbol for Protagonist Therapeutics?
Protagonist Therapeutics trades under the ticker PTGX on the Nasdaq.
What is Protagonist Therapeutics's market cap?
Protagonist Therapeutics is a mid cap stock with a market cap of about 9.3 billion dollars.
How does Protagonist Therapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves PTGX stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow PTGX stock every day?
Add PTGX to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.